ARPC3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB300-895
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Predicted:
Bovine (100%), Canine (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-RQFMNKSLSGPGQ corresponding to C-Terminus according to NP_005710.1.
Specificity
Please note there are two hypothetical proteins called "similar to the Arp2/3 protein complex subunit p21-Arc" that are virtually identical (CAC14083, XP_208062).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for ARPC3 Antibody
Western Blot: ARPC3 Antibody [NB300-895]
Western Blot: ARPC3 Antibody [NB300-895] - (1ug/ml) of Mouse Brain lysate (RIPA buffer, 35ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.Applications for ARPC3 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:16000
Western Blot
1 - 3 ug/ml
Application Notes
WB: Band observed just below 20 kDa band marker in Hela, human brain and mouse brain lysates (predicted MW of 20 kDa band according to NP_005710).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: ARPC3
Alternate Names
actin related protein 2/3 complex, subunit 3, 21kDa, subunit 3 (21 kD)
Gene Symbol
ARPC3
UniProt
Additional ARPC3 Products
Product Documents for ARPC3 Antibody
Product Specific Notices for ARPC3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...